Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARIETTA: Biomarkers in Severe Asthma
NCT02537691Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2015
- Primary completion
- Jul 2017
- Countries
- 15
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Roche. Primary endpoint: Mean Number of Asthma Exacerbations in Participants With High Baseline Periostin Compared to participants With Low Baseline Periostin at 52 weeks. Started Aug 2015; status: completed.
Beyond the preview
Go deeper on NCT02537691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537691.